Ahead of Synopsys (SNPS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

21.05.26 15:15 Uhr

Werte in diesem Artikel
Aktien

43,06 EUR 1,93 EUR 4,69%

400,00 EUR -3,00 EUR -0,74%

Indizes

29.884,7 PKT 75,6 PKT 0,25%

26.144,1 PKT 104,1 PKT 0,40%

7.525,8 PKT 42,6 PKT 0,57%

Wall Street analysts forecast that Synopsys (SNPS) will report quarterly earnings of $3.17 per share in its upcoming release, pointing to a year-over-year decline of 13.6%. It is anticipated that revenues will amount to $2.25 billion, exhibiting an increase of 40.3% compared to the year-ago quarter.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.Bearing this in mind, let's now explore the average estimates of specific Synopsys metrics that are commonly monitored and projected by Wall Street analysts.The consensus estimate for 'Revenue- Maintenance and service' stands at $708.37 million. The estimate indicates a change of +167% from the prior-year quarter.The combined assessment of analysts suggests that 'Revenue- Total products revenue' will likely reach $1.54 billion. The estimate indicates a year-over-year change of +15.3%.The average prediction of analysts places 'Revenue by segment- Design IP' at $439.19 million. The estimate suggests a change of -8.9% year over year.Analysts forecast 'Revenue by segment- Design Automation' to reach $1.67 billion. The estimate indicates a year-over-year change of +48.7%.The consensus among analysts is that 'Revenue- Upfront products' will reach $455.68 million. The estimate points to a change of -10.8% from the year-ago quarter.It is projected by analysts that the 'Revenue- Time-based products' will reach $1.08 billion. The estimate points to a change of +30.1% from the year-ago quarter. View all Key Company Metrics for Synopsys here>>> Over the past month, shares of Synopsys have returned +4.5% versus the Zacks S&P 500 composite's +4.6% change. Currently, SNPS carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Synopsys Inc.

Analysen zu Synopsys Inc.

DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
22.08.2019Synopsys BuyNeedham & Company, LLC
03.04.2019Synopsys BuyNeedham & Company, LLC
28.03.2019Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyNeedham & Company, LLC
06.12.2018Synopsys BuyThe Benchmark Company
DatumRatingAnalyst
09.09.2015Synopsys HoldThe Benchmark Company
04.12.2008Synopsys UpgradeCitigroup Corp.
02.02.2007Synopsys neutralDA Davidson
31.01.2007Update Synopsys Inc.: NeutralDA Davidson
30.11.2006Synopsys holdDeutsche Securities
DatumRatingAnalyst
21.08.2008Synopsys DowngradeCitigroup Corp.
24.06.2005Synopsys underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synopsys Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen